Strategic merger Globe and NuVasive merger creates one of the most comprehensive musculoskeletal procedural solution offerings, presenting cross-sell opportunities across spine, orthopedics, and minimally invasive technologies to expand addressable surgeons and hospital programs.

Global reach Combined footprint enhances global market access and support capabilities, enabling sales teams to propose end-to-end spine and musculoskeletal solutions to healthcare systems seeking integrated care pathways.

Clinical leadership Ongoing commitment to clinical education and research partnerships with societies like Scoliosis Research Society opens doors for sponsor-led programs, thought leadership engagements, and case-based training to drive adoption of new technologies.

Technology stack Adoption of standardized tools such as OneStream, DocuSign, and regulatory compliance frameworks (IEC 62304) indicates scalable, enterprise-grade operations that can facilitate faster procurement, contract execution, and post-market surveillance discussions with hospitals.

Financial momentum Post-merger growth signals from Q1 FY2024 and revised sales guidance suggest expanding total addressable market and margin expansion potential, creating opportunities for value-based discussions around cost-per-procedure, efficiency, and integrated device-therapy bundles.